Ovarian cancer
Conditions
Interventions
Ovarian Benign Mass Group:None
Sponsors
Second Xiangya Hospital of CSU
Eligibility
Sex/Gender
Female
Age
35 Years to No maximum
Inclusion criteria
Inclusion criteria: Ovarian cancer enrollment criteria: confirmed epithelial OC, such as: serous carcinoma, clear cell carcinoma, endometrioid carcinoma, etc., of which 80% are serous carcinoma and 20% are others. 1. Stage I 40%, Stage II 40%, Stage III 10%, Stage IV 10%; 2. No history of treatment, no surgery, no drug use; 3. > 35 years old; 4. Enrollment criteria for benign ovarian mass group: high-risk samples of ovarian cancer, such as ovarian mass, lump, and cyst. Telephone return visit once every 6 months. If there is a clinical diagnosis, please provide detailed diagnostic information. healthy people; 5.> 35 years old; High-risk populations 1. High-risk samples for ovarian cancer, such as ovarian masses, lumps, cysts. Telephone return visit once in 6 months. If there is a clinical diagnosis, please provide detailed diagnostic information; 2. > 35 years old
Exclusion criteria
Exclusion criteria: 1) Have a history of any cancer except ovarian cancer; 2) Other extraovarian serious diseases, especially major diseases with a survival time of < 3 years; 3) There are factors that affect the diagnostic examination of the disease (e.g., MRI-related pacemaker, ferromagnetic implants, etc.); 4) Known history of allogeneic organ transplantation and allogeneic hematopoietic stem cell transplantation; 5) Known history of primary immunodeficiency; 6) history of blood transfusion within 1 month; 7) Blood draw is risky (e.g., hemophilia, severe anemia - Hb less than 8.0gm/dL); 8) Female patients who are pregnant or trying to become pregnant; 9) Any other condition that, in the opinion of the investigator, may not be suitable for inclusion in the study or may interfere with the completion of the study; 10) Unable to provide informed consent or refuse to draw blood.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whole Genome Methylation Analysis Data; | — |
Countries
China
Contacts
Public ContactFu Chun
Second Xiangya Hospital of CSU
Outcome results
None listed